SlideShare a Scribd company logo
1
BIOTERRORISM 3
The intended use of biological weapons to cause disease in
humans, animals, and plants, as an act of war. Biological
weapons deliberately disseminate disease producing
organisms or toxins and achieves this effect through
multiplication within a target host.
Forms of Bioterrorism 3
Classic Terrorism
• Against person &
Institutions.
Agri-Bioterrorism
• Against
crops/foods/plants
Product tampering
• Directed against
consumer/
commercial
products
CLASSIFICATION 4
Category A
• Early disseminated
• High mortality rates
• Major public health
impact
• Public panic and social
disruption
Category B
• Moderately easy to
disseminate
• Low mortality rates
Category
Category C
• Emerging pathogens
• Could be engineered for
mass dissemination in
the future
5
Category A agents
Bacteria Viruses
Anthrax (Bacillus anthracis) Viral hemorrhagic fevers
Botulism (Clostridium botulinum toxin) Arenaviruses: Lassa, New World
(Machupo, Junin, Guanarito, and Sabia)
Plague (Yersinia pestis) Bunyaviridae: Crimean Congo, Rift
Valley
Smallpox (Variola major) Filoviridae: Ebola, Marburg
Tularemia (Francisella tularensis) Flaviviridae: Yellow fever; Omsk fever;
Kyasanur Forest
6
Anthrax
 Anthrax is a noncontagious
disease caused by the spore-
forming bacterium Bacillus
anthracis.
 An anthrax vaccine does exist
but requires many injections
for stable use.
7
Small Pox
 Smallpox is a highly contagious
virus.
 It is transmitted easily through
the atmosphere and has a high
mortality rate (20-40%).
 Smallpox was eradicated in the
world in the 1970s, thanks to a
worldwide vaccination program.
8
EBOLA
 First recorded outbreak at,Yambuku in
democratic republic of congo (EBOLA
RIVER).
 Viruses do not contain enzymes for
energy production or protein synthesis.
 Small infectious agent that replicates
only inside the living cells of other
organisms.
 No licensed vaccine for EVD is
available. Several vaccines are being
tested, but none are available for
clinical use.
9
Category B agents
 Category B agents are moderately easy to disseminate and have low mortality rates.
1. Brucellosis (Brucella spp.)
2. Clostridium perfringens
3. Glanders (Burkholderia mallei)
4. Melioidosis (B. pseudomallei)
5. Psittacosis (Chlamydia psittaci)
6. Q fever (Coxiella burnetii)
7. Ricin toxin from Ricinus communis (castor beans)
8. Typhus fever
10
Food safety threats:
Salmonella sp.
Escherichia coli
Shigella sp.
Water safety threats:
Vibrio cholerae
Cryptosporidium parvum
Ricinus communis Burkholderia mallei
Chlamydia psittaci Coxiella burnetii
11
Category C agents
 Category C agents are emerging pathogens that might be engineered for mass dissemination
because of their:
A. Availability
B. Ease of production and dissemination
C. High mortality rate
D. Ability to cause a major health impact.
Nipah Virus Hanta Virus
Example:
1. Nipah Virus
2. Hanta Virus
3. SARS
4. H1N1 a strain of Influenza
5. HIV/AIDS SARS Virus HIV Virus
12
Signs of Bioterrorism
 Outbreak of a rare disease.
 Seasonal disease at a wrong time.
 Unusual age distribution.
 Unusual clinical symptoms.
 Unusual epidemiologic features.
 Outbreak in a region / geographic location where it is not normally seen.
13
Early Preparation
 Familiarize medical staffs with agents of Bioterrorism.
 Incorporate into disaster planning –
• Decontamination & infection control.
• Communication with key agencies- Laboratory, Respective national
health authorities.
• Contacts to obtain stockpiled supplies – Antibiotics, Immune sera,
Vaccines, etc.
• Security preparations.
14
Preparedness
 Biological agents are relatively
easy to obtain by terrorists and
laboratories are working on
advanced detection systems to
provide:
1. Early warning
2. Identify contaminated areas and
Populations at risk
3. To facilitate prompt treatment.
15
Bioterrorism in Bangladesh
 Bangladesh is more vulnerable to biological threat because of dense
susceptible population, poverty, inadequate response capacity.
 Recent events including of deaths and cases relating to anthrax infection are
found to be linked to acts of terrorism in the country.
 Bangladesh is also suffering from the small pox .
 Though bioterrorism isn’t still acute but the government should take necessary
steps to prevent it as intellectual crime in the world is increasing day by day .
16
Conclusion
 National level mass awareness programs should be arranged.
 Practical steps should be taken.
 Every person must take care of himself and his dear ones.
 Legislation should be made.
 Improve conditions of urban areas.
17
18

More Related Content

What's hot

Bioweapons
Bioweapons Bioweapons
Bioweapons
Vîñàý Pãtêl
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
drshameera
 
bio terrorism
bio terrorismbio terrorism
bio terrorism
Aisha Kz
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
Pramudha NM
 
Presentation on bioterrorism
Presentation on bioterrorismPresentation on bioterrorism
Presentation on bioterrorism
BijayKumarMahato1
 
Bioterrorism (2)
Bioterrorism (2)Bioterrorism (2)
Bioterrorism (2)
Aparna Ramachandran
 
Biological warfare
Biological warfareBiological warfare
Biological warfare
Pritam Kolge
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
ADESH MEDICAL COLLEGE
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorismsangram96
 
Biowarefare
BiowarefareBiowarefare
Biowarefare
misbah malik
 
Bioweapon
BioweaponBioweapon
Bioweapon
mohammed Qazzaz
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
Rikin Hasnani
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
Bivek Rai
 
Zika virus outbreak,2016
Zika virus outbreak,2016Zika virus outbreak,2016
Zika virus outbreak,2016
Ruhul Amin
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
Kumar Mrigesh
 
Bio terrorism
Bio terrorismBio terrorism
Bio terrorism
keshob ghosh
 
Biological weapons
Biological weapons Biological weapons
Biological weapons
XadafAttique
 
Bioterrorism 29.03.2020
Bioterrorism   29.03.2020Bioterrorism   29.03.2020
Bioterrorism 29.03.2020
swati shikha
 

What's hot (20)

Bioweapons
Bioweapons Bioweapons
Bioweapons
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
bio terrorism
bio terrorismbio terrorism
bio terrorism
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
Biological warfare
Biological warfareBiological warfare
Biological warfare
 
Presentation on bioterrorism
Presentation on bioterrorismPresentation on bioterrorism
Presentation on bioterrorism
 
Bioterrorism (2)
Bioterrorism (2)Bioterrorism (2)
Bioterrorism (2)
 
Biological warfare
Biological warfareBiological warfare
Biological warfare
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
Biowarefare
BiowarefareBiowarefare
Biowarefare
 
Bioweapon
BioweaponBioweapon
Bioweapon
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
Zika virus outbreak,2016
Zika virus outbreak,2016Zika virus outbreak,2016
Zika virus outbreak,2016
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
Bio terrorism
Bio terrorismBio terrorism
Bio terrorism
 
Biological warfare
Biological warfareBiological warfare
Biological warfare
 
Biological weapons
Biological weapons Biological weapons
Biological weapons
 
Bioterrorism 29.03.2020
Bioterrorism   29.03.2020Bioterrorism   29.03.2020
Bioterrorism 29.03.2020
 

Similar to Bioterrorism (Southeast University)

Bioterror.ppt
Bioterror.pptBioterror.ppt
Bioterror.ppt
sharvani23
 
Global Pandemic and Emerging Diseases ...
Global Pandemic and Emerging Diseases ...Global Pandemic and Emerging Diseases ...
Global Pandemic and Emerging Diseases ...
ndagiremilly90
 
Bioterrorism / Biological warfare created by Dr. X
Bioterrorism / Biological warfare created by Dr. XBioterrorism / Biological warfare created by Dr. X
Bioterrorism / Biological warfare created by Dr. X
SayianJude
 
Man Vs Microbe - Pre-Apocalyptic Phase Failed? in IJAHS
Man Vs Microbe - Pre-Apocalyptic Phase Failed? in IJAHSMan Vs Microbe - Pre-Apocalyptic Phase Failed? in IJAHS
Man Vs Microbe - Pre-Apocalyptic Phase Failed? in IJAHSPreethi Selvaraj
 
Microorganisms in biological warfare
Microorganisms in biological warfareMicroorganisms in biological warfare
Microorganisms in biological warfare
Neha Agarwal
 
CDC AR Threats Report'2019 - Key Highlights
CDC AR Threats Report'2019 - Key HighlightsCDC AR Threats Report'2019 - Key Highlights
CDC AR Threats Report'2019 - Key Highlights
TeamZevac
 
Biological disaster management
Biological disaster managementBiological disaster management
Biological disaster managementNaveen S
 
Control and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptxControl and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptx
Bhoj Raj Singh
 
Vaccination: Be immunized to have a healthy life
Vaccination: Be immunized to have a healthy lifeVaccination: Be immunized to have a healthy life
Vaccination: Be immunized to have a healthy life
Nimisha Tewari
 
Vaccination
VaccinationVaccination
5-Bioterrerism.ppt
5-Bioterrerism.ppt5-Bioterrerism.ppt
5-Bioterrerism.ppt
nedalalazzwy
 
Bioterrorism
BioterrorismBioterrorism
A presentaion on biological disaster
A presentaion on biological disasterA presentaion on biological disaster
A presentaion on biological disasterDocumentStory
 
Threats and preventions of bioterrorism
Threats and preventions of bioterrorismThreats and preventions of bioterrorism
Threats and preventions of bioterrorismNida Sajjad
 
Vaccines against infectious diseases
Vaccines against infectious diseasesVaccines against infectious diseases
Vaccines against infectious diseases
KanishkPatel6
 
CategoryABiologicalEffort.pptx
CategoryABiologicalEffort.pptxCategoryABiologicalEffort.pptx
CategoryABiologicalEffort.pptx
ARYAN552812
 
bioterrorism-170215073558.pdf
bioterrorism-170215073558.pdfbioterrorism-170215073558.pdf
bioterrorism-170215073558.pdf
NamanMishra87
 
Vdds2
Vdds2Vdds2

Similar to Bioterrorism (Southeast University) (20)

Bioterror.ppt
Bioterror.pptBioterror.ppt
Bioterror.ppt
 
Global Pandemic and Emerging Diseases ...
Global Pandemic and Emerging Diseases ...Global Pandemic and Emerging Diseases ...
Global Pandemic and Emerging Diseases ...
 
Bioterrorism / Biological warfare created by Dr. X
Bioterrorism / Biological warfare created by Dr. XBioterrorism / Biological warfare created by Dr. X
Bioterrorism / Biological warfare created by Dr. X
 
Man Vs Microbe - Pre-Apocalyptic Phase Failed? in IJAHS
Man Vs Microbe - Pre-Apocalyptic Phase Failed? in IJAHSMan Vs Microbe - Pre-Apocalyptic Phase Failed? in IJAHS
Man Vs Microbe - Pre-Apocalyptic Phase Failed? in IJAHS
 
Microorganisms in biological warfare
Microorganisms in biological warfareMicroorganisms in biological warfare
Microorganisms in biological warfare
 
CDC AR Threats Report'2019 - Key Highlights
CDC AR Threats Report'2019 - Key HighlightsCDC AR Threats Report'2019 - Key Highlights
CDC AR Threats Report'2019 - Key Highlights
 
Biological disaster management
Biological disaster managementBiological disaster management
Biological disaster management
 
Biowarfare
Biowarfare Biowarfare
Biowarfare
 
Control and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptxControl and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptx
 
Vaccination: Be immunized to have a healthy life
Vaccination: Be immunized to have a healthy lifeVaccination: Be immunized to have a healthy life
Vaccination: Be immunized to have a healthy life
 
Vaccination
VaccinationVaccination
Vaccination
 
5-Bioterrerism.ppt
5-Bioterrerism.ppt5-Bioterrerism.ppt
5-Bioterrerism.ppt
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
A presentaion on biological disaster
A presentaion on biological disasterA presentaion on biological disaster
A presentaion on biological disaster
 
Threats and preventions of bioterrorism
Threats and preventions of bioterrorismThreats and preventions of bioterrorism
Threats and preventions of bioterrorism
 
Rotavirus kellermann 20121129
Rotavirus kellermann 20121129Rotavirus kellermann 20121129
Rotavirus kellermann 20121129
 
Vaccines against infectious diseases
Vaccines against infectious diseasesVaccines against infectious diseases
Vaccines against infectious diseases
 
CategoryABiologicalEffort.pptx
CategoryABiologicalEffort.pptxCategoryABiologicalEffort.pptx
CategoryABiologicalEffort.pptx
 
bioterrorism-170215073558.pdf
bioterrorism-170215073558.pdfbioterrorism-170215073558.pdf
bioterrorism-170215073558.pdf
 
Vdds2
Vdds2Vdds2
Vdds2
 

Recently uploaded

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 

Recently uploaded (20)

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 

Bioterrorism (Southeast University)

  • 1. 1
  • 2. BIOTERRORISM 3 The intended use of biological weapons to cause disease in humans, animals, and plants, as an act of war. Biological weapons deliberately disseminate disease producing organisms or toxins and achieves this effect through multiplication within a target host.
  • 3. Forms of Bioterrorism 3 Classic Terrorism • Against person & Institutions. Agri-Bioterrorism • Against crops/foods/plants Product tampering • Directed against consumer/ commercial products
  • 4. CLASSIFICATION 4 Category A • Early disseminated • High mortality rates • Major public health impact • Public panic and social disruption Category B • Moderately easy to disseminate • Low mortality rates Category Category C • Emerging pathogens • Could be engineered for mass dissemination in the future
  • 5. 5
  • 6. Category A agents Bacteria Viruses Anthrax (Bacillus anthracis) Viral hemorrhagic fevers Botulism (Clostridium botulinum toxin) Arenaviruses: Lassa, New World (Machupo, Junin, Guanarito, and Sabia) Plague (Yersinia pestis) Bunyaviridae: Crimean Congo, Rift Valley Smallpox (Variola major) Filoviridae: Ebola, Marburg Tularemia (Francisella tularensis) Flaviviridae: Yellow fever; Omsk fever; Kyasanur Forest 6
  • 7. Anthrax  Anthrax is a noncontagious disease caused by the spore- forming bacterium Bacillus anthracis.  An anthrax vaccine does exist but requires many injections for stable use. 7
  • 8. Small Pox  Smallpox is a highly contagious virus.  It is transmitted easily through the atmosphere and has a high mortality rate (20-40%).  Smallpox was eradicated in the world in the 1970s, thanks to a worldwide vaccination program. 8
  • 9. EBOLA  First recorded outbreak at,Yambuku in democratic republic of congo (EBOLA RIVER).  Viruses do not contain enzymes for energy production or protein synthesis.  Small infectious agent that replicates only inside the living cells of other organisms.  No licensed vaccine for EVD is available. Several vaccines are being tested, but none are available for clinical use. 9
  • 10. Category B agents  Category B agents are moderately easy to disseminate and have low mortality rates. 1. Brucellosis (Brucella spp.) 2. Clostridium perfringens 3. Glanders (Burkholderia mallei) 4. Melioidosis (B. pseudomallei) 5. Psittacosis (Chlamydia psittaci) 6. Q fever (Coxiella burnetii) 7. Ricin toxin from Ricinus communis (castor beans) 8. Typhus fever 10 Food safety threats: Salmonella sp. Escherichia coli Shigella sp. Water safety threats: Vibrio cholerae Cryptosporidium parvum
  • 11. Ricinus communis Burkholderia mallei Chlamydia psittaci Coxiella burnetii 11
  • 12. Category C agents  Category C agents are emerging pathogens that might be engineered for mass dissemination because of their: A. Availability B. Ease of production and dissemination C. High mortality rate D. Ability to cause a major health impact. Nipah Virus Hanta Virus Example: 1. Nipah Virus 2. Hanta Virus 3. SARS 4. H1N1 a strain of Influenza 5. HIV/AIDS SARS Virus HIV Virus 12
  • 13. Signs of Bioterrorism  Outbreak of a rare disease.  Seasonal disease at a wrong time.  Unusual age distribution.  Unusual clinical symptoms.  Unusual epidemiologic features.  Outbreak in a region / geographic location where it is not normally seen. 13
  • 14. Early Preparation  Familiarize medical staffs with agents of Bioterrorism.  Incorporate into disaster planning – • Decontamination & infection control. • Communication with key agencies- Laboratory, Respective national health authorities. • Contacts to obtain stockpiled supplies – Antibiotics, Immune sera, Vaccines, etc. • Security preparations. 14
  • 15. Preparedness  Biological agents are relatively easy to obtain by terrorists and laboratories are working on advanced detection systems to provide: 1. Early warning 2. Identify contaminated areas and Populations at risk 3. To facilitate prompt treatment. 15
  • 16. Bioterrorism in Bangladesh  Bangladesh is more vulnerable to biological threat because of dense susceptible population, poverty, inadequate response capacity.  Recent events including of deaths and cases relating to anthrax infection are found to be linked to acts of terrorism in the country.  Bangladesh is also suffering from the small pox .  Though bioterrorism isn’t still acute but the government should take necessary steps to prevent it as intellectual crime in the world is increasing day by day . 16
  • 17. Conclusion  National level mass awareness programs should be arranged.  Practical steps should be taken.  Every person must take care of himself and his dear ones.  Legislation should be made.  Improve conditions of urban areas. 17
  • 18. 18